High doses of vitamin D may not affect COVID-19 severity or number of hospital visits, however, it may slightly reduce the ...
While vitamin D3 does not improve immediate COVID-19 outcomes or reduce medical visits, it may lower the risk of developing ...
WallabyPhenox is preparing to initiate PIANO , a landmark U.S. clinical trial designed to expand access to flow diversion therapy within one of the fastest-growing segments of the neurovascular market ...
The 7 mg dose of OV329 demonstrated favorable safety and tolerability profile, reinforcing best-in-category potential for ...
Ovid Therapeutics (OVID) shares jumped over 40% premarket as the biopharmaceutical company reported favorable safety and tolerability results for the 7 mg dose of its OV329 epilepsy drug, while ...
And thanks for Stifel for having us here this afternoon. So yes, if I look at 2026 as we exited the prior year, we're entering this year, with a great deal of enterprise-wide momentum, and this comes ...
Two international studies, a clinical trial led by the University of Oxford and University of Utrecht, and a qualitative ...
An innovative care delivery model at Mayo Clinic integrates virtual oversight, remote patient monitoring, mobile health ...
Thank you. This is one of the largest unmet needs in all of medicine, and we at ClearPoint Neuro, Inc. believe we can play a ...
Among adults with chronic rhinosinusitis with nasal polyps, those receiving verekitug vs. placebo at baseline and week 12 had ...
Achieved randomization target of 230 patients in LEVEL study, topline data expected in third quarter of 2026 Initiated global ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results